In 2019, the coronavirus pandemic broke out as a serious public health issue worldwide. In Côte d'Ivoire, the number of cases of COVID-19 has increased rapidly. The Severe Acute Respiratory Syndrome virus (SARS-CoV-2) binds to angiotensin converting enzyme 2 (ACE2) receptors in the respiratory tracts and enters the respiratory and alveolar cells of infected patients. Deficiency of fat-soluble vitamin D 3 is associated with respiratory distress syndrome and pulmonary fibrosis by activation of the renin-angiotensin system. In Côte d'Ivoire, very little research is being done on SARS-CoV-2 and vitamin D. The objective of this study was to assess the vitamin D status of people infected and suffering from COVID-19 in order to contribute to their medical treatment. The study involved 100 adults infected with SARS-CoV-2 (24 women and 76 men). After confirmation of the patient's SARS-CoV-2 status by RT-PCR, the 25 (OH) vitamin D assay was performed on the Cobas 6000 device and compared to control subjects, the non-COVID-19 positive. A significant decrease in 25-hydroxy vitamin D 3 concentrations (44 ± 1.29 nmole/L) was observed in patients infected with SARS-CoV-2, compared to control (78 ± 0.68 nmole/L) (p < 0.0001). The 25-hydroxy vitamin D 3 deficiency requires vitamin D supplementation in the management of hospitalized patients infected with SARS-CoV-2.
Background: Micronutrients play an important role in the human immune system. During HIV infection, the virus utilises the micronutrients of the body, for its replication causing metabolic disorders including phosphocalcic. Parathyroid hormone (PTH), vitamin D3 (25-hydroxyvitamin D3) and calcitonin are essential for the maintenance of phosphocalcic homeostasis and the proper functioning of the body. In Côte d'Ivoire, very few studies on HIV infection and the mechanism of phosphocalcic metabolism have been done. The purpose of this study was to determine the status of 25 (OH) D3 and parathyroid hormone in people living with HIV. Methodology: The study involved 326 adults (163 HIV-positive and 163 HIV-negative as control subjects). After confirmation by HIV serologic scanning result, CD4 count was performed by flow cytometry (Facs Calibur). Assays for 25 (OH) D3 and PTH were performed by HPLC and COBAS 6000 automated systems, respectively. Results: A decrease in mean values of 25 (OH) D3 (16 ± 0.46 ng / mL) was observed in 50% of HIV-infected on ART and 87% of these patients presented a normal PTH level (28 ± 1.95 pg / mL). Deficiency of 25 (OH) D3 (20 ± 1.03 ng / mL) is higher in HIV-infected on ART who have a CD4 count < 200 cells / mL. Conclusion: Parathyroid hormone levels were normal in this study. Insufficiency or deficiency of 25-hydroxyvitamin D3 is more common in HIV-infected on ART with a CD4 count < 200 cells / mL. This decrease characterized the degree of immunodepression.
Background:A number of studies have highlighted the phosphocalcic balance disorder and posed the problem of the correlation between 25-hydroxyvitamin D 3 and parathyroid hormone in people living with HIV (PLHIV). However, few studies have been conducted on the link between antiretroviral therapy and the level of 25 (OH) D 3 during HIV infection. The objective of this study was to evaluate 25 (OH) D 3 and the parathyroid status in HIV-infected people taking antiretroviral treatment in Côte d'Ivoire.
Aims: This study was to identify mutations in patients’ vitamin D receptor (VDR) gene in Côte d'Ivoire, precisely in Human immunodeficiency virus (HIV) patients deficient in vitamin D3. Methodology: Fifty (50) DNA extractions from peripheral blood mononuclear cells collected from HIV positive and vitamin D3 deficient patients were analyzed after verifying their integrity by quantification of genomic DNA and migration from agarose gel. The use of the restriction enzymes Dpn I, Bg III and Pst I made it possible to carry out the PCR-RLFP of the fragments Fok-1 in exon 2, Bsm-1 and Apa-1 in intron 8 and Taq-1 in exon 9. Results: The analysis of the DNA fragments Fok-1 in exon 2 and Bsm-1 in intron 8 of the VDR gene from HIV positive patients deficient in vitamin D3 showed a significantly high prevalence of mutant genotype (100% and 98%) respectively p = 0.0001. Furthermore, in this study, a prevalence of 6% of mutant genotype was observed in Taq-1 of exon 9 of the VDR gene. Conclusion: The high prevalence of mutant genotypes observed in the DNA fragments of Fok-1 in exon 2 and Bsm-1 in intron 8 of the VDR gene studied confirms the presence of mutations in the VDR gene of these patients. It would, therefore, be necessary to sequence the DNA fragments with mutations in order to identify the mutations that affect the VDR gene and that are responsible for the vitamin D3 deficiency observed in these patients.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.